Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018
- PMID: 37461745
- PMCID: PMC10351615
- DOI: 10.3389/fviro.2022.936191
Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018
Abstract
Yellow fever virus (YFV) is the causative agent of yellow fever (YF), a hemorrhagic and viscerotropic acute disease. Severe YF has been described in approximately 15-25% of YF patients, with 20-50% of severe YF cases being fatal. Here we analyzed cerebrospinal fluid (CSF) samples collected during the YF outbreak in Brazil in 2018, aiming to investigate CNS neuroinvasion in fatal YFV cases. YFV RNA was screened by RT-qPCR targeting the 3'UTR region of the YFV genome in CSF. CSF samples were tested for the presence of anti-YFV IgM and neutralizing antibodies, coupled with routine laboratory examinations. Among the 13 patients studied, we detected anti-YFV IgM in CSF from eight patients and YFV RNA in CSF from five patients. YFV RNA genomic load in CSF samples ranged from 1.75×103 to 5.42×103 RNA copies/mL. We genotyped YFV from three CSF samples that grouped with other YFV samples from the 2018 outbreak in Brazil within the South-American I genotype. Even though descriptions of neurologic manifestations due to wild type YFV (WT-YFV) infection are rare, since the last YF outbreak in Brazil in 2017-2018, a few studies have demonstrated WT-YFV RNA in CSF samples from YF fatal cases. Serological tests indicated the presence of IgM and neutralizing antibodies against YFV in CSF samples from two patients. Although the presence of viral RNA, IgM and neutralizing antibodies in CSF samples could indicate neuroinvasiveness, further studies are needed to better elucidate the role of YFV neuroinvasion and possible impacts in disease pathogenesis.
Keywords: Yellow fever virus; central nervous system; cerebrospinal fluid; neurotropic; wild-type Yellow fever virus; yellow fever.
Conflict of interest statement
Conflict of interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Yellow Fever Molecular Diagnosis Using Urine Specimens during Acute and Convalescent Phases of the Disease.J Clin Microbiol. 2022 Aug 17;60(8):e0025422. doi: 10.1128/jcm.00254-22. Epub 2022 Aug 2. J Clin Microbiol. 2022. PMID: 35916519 Free PMC article.
-
Yellow fever virus investigation in tissues of vampire bats Desmodus rotundus during a wild yellow fever outbreak in Brazilian Atlantic Forest.Comp Immunol Microbiol Infect Dis. 2022 Oct;89:101869. doi: 10.1016/j.cimid.2022.101869. Epub 2022 Sep 1. Comp Immunol Microbiol Infect Dis. 2022. PMID: 36115128
-
YELLOW ALERT: Persistent Yellow Fever Virus Circulation among Non-Human Primates in Urban Areas of Minas Gerais State, Brazil (2021-2023).Viruses. 2023 Dec 23;16(1):31. doi: 10.3390/v16010031. Viruses. 2023. PMID: 38257732 Free PMC article.
-
Understanding yellow fever-associated myocardial injury: an autopsy study.EBioMedicine. 2023 Oct;96:104810. doi: 10.1016/j.ebiom.2023.104810. Epub 2023 Sep 25. EBioMedicine. 2023. PMID: 37757571 Free PMC article. Review.
-
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.Curr Treat Options Infect Dis. 2020;12(4):398-409. doi: 10.1007/s40506-020-00237-2. Epub 2020 Nov 6. Curr Treat Options Infect Dis. 2020. PMID: 33173445 Free PMC article. Review.
Cited by
-
1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure-Activity Relationship.ACS Omega. 2023 Nov 1;8(45):42951-42965. doi: 10.1021/acsomega.3c06106. eCollection 2023 Nov 14. ACS Omega. 2023. PMID: 38024733 Free PMC article.
-
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.Microbiol Spectr. 2024 May 2;12(5):e0370323. doi: 10.1128/spectrum.03703-23. Epub 2024 Mar 21. Microbiol Spectr. 2024. PMID: 38511952 Free PMC article.
-
Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.Viruses. 2024 May 15;16(5):787. doi: 10.3390/v16050787. Viruses. 2024. PMID: 38793668 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources